STUDY OF THE ANTIDEPRESSANT ACTIVITY OF FOLIC ACID AND VITAMIN-D ON RESERPINE INDUCED DEPRESSION IN MICE.

  • Borah L Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India
  • Lahkar M Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India
  • Dasgupta S Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India

Abstract

 Objective: Low levels of folic acid and deficiency of Vitamin D have been found to be associated with poor mood and depression. This study was designed to investigate whether these vitamins show antidepressant activity in models of depression in mice.

Methods: Reserpine was used to induce depression in the study groups. Low and high doses of folic acid and Vitamin D as well as combinations of these vitamins in low and high doses were administered after induction of depression. The test animals were then tested on forced swim test, tail suspension test, and open field test models for evaluation of the antidepressant activity.

Results: After 2 weeks of drug treatment, all the treated groups showed a significant reduction in immobility time in both the test models (p<0.05). High dose folic acid showed consistently greater antidepressant property in all the test models throughout the study period. High dose Vitamin D (p<0.05) also showed good antidepressant activity after 2 weeks, the delayed antidepressant effect of which might be attributable to the molecular mechanism of action of Vitamin D.

Conclusion: Our study demonstrates that both folic acid and Vitamin D have antidepressant activity. The antidepressant activity of high dose folic acid (50 mg/kg) in reserpine-induced depression in mice at the end of 2 weeks was more pronounced in our study. Studies with longer duration of treatment are warranted to further evaluate their antidepressant effect.

Keywords: Folic acid, Vitamin D, Reserpine, Depression, Tail suspension test, Forced swim test.

Author Biographies

Borah L, Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India
Department of Pharmacology, Assistant Professor
Lahkar M, Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India
Department of Pharmacology, Professor
Dasgupta S, Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India
Department of Pharmacology, Postgraduate trainee

References

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
2. Zam WI. Vitamin D deficiency and depressive disorders: Review study of probable relationship. Int J Pharm Pharm Sci 2016;8:16-22.
3. Cerdá M, Sagdeo A, Galea S. Comorbid forms of psychopathology: Key patterns and future research directions. Epidemiol Rev 2008;30:155-77.
4. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008 3;358:55-68.
5. Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003;26:137-46.
6. Taylor MJ, Carney SM, Goodwin GM, Geddes JR. Folate for depressive disorders: Systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol 2004;18:251-6.
7. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about Vitamin D functions in the nervous system. Trends Endocrinol Metab 2002;13:100-5.
8. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the Vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005;29:21-30.
9. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Struct Funct 2008;213:93-118.
10. Berk M, Sanders KM, Pasco JA, Jacka FN, Williams LJ, Hayles AL, et al. Vitamin D deficiency may play a role in depression. Med Hypotheses 2007;69:1316-9.
11. Brocardo PS, Budni J, Kaster MP, Santos AR, Rodrigues AL. Folic acid administration produces an antidepressant-like effect in mice: Evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 2008;54:464-73.
12. Tan ZX, Chen YH, Xu S, Qin HY, Zhang C, Zhao H, et al. Calcitriol inhibits bleomycin-induced early pulmonary inflammatory response and epithelial-mesenchymal transition in mice. Toxicol Lett 2016;240:161-71.
13. Ikram H, Haleem DJ. Repeated treatment with reserpine as a progressive animal model of depression. Pak J Pharm Sci 2017;30:897-902.
14. Walia V. Influence of stress and fluoxetine on immobility period of mice in tail suspension test and forced swim test. Asian J Pharm Clin Res 2016;9:302-5.
15. Patel S, Rajshree N, Shah P. Evaluation of antidepressant activity of herbomineral formulation. Int J Pharm Pharm Sci 2016;8:145-7.
16. Budni J, Zomkowski AD, Engel D, Santos DB, dos Santos AA, Moretti M, et al. Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice. Exp Neurol 2013;240:112-21.
17. Fedotova J, Dudnichenko T, Kruzliak P, Puchavskaya Z. Different effects of Vitamin D hormone treatment on depression-like behavior in the adult ovariectomized female rats. Biomed Pharmacother 2016;84:1865-72.
Statistics
257 Views | 276 Downloads
How to Cite
L, B., L. M, and D. S. “STUDY OF THE ANTIDEPRESSANT ACTIVITY OF FOLIC ACID AND VITAMIN-D ON RESERPINE INDUCED DEPRESSION IN MICE.”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 11, no. 2, Feb. 2018, pp. 255-9, doi:10.22159/ajpcr.2018.v11i2.20408.
Section
Original Article(s)